General Growth Properties, Inc. - SWOT Analysis

MarketLine
September 29, 2011
27 Pages - SKU: MTLN6649982
Genethon - Product Pipeline Review - 2015
2/24/2015 | published by: Global Markets Direct
Genethon - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Genethon - Product Pipeline Review - 2015’, provides an overview of the Genethon’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic  |  read more...
USD 1,500
Ganymed Pharmaceuticals AG - Product Pipeline Review - 2015
2/24/2015 | published by: Global Markets Direct
Ganymed Pharmaceuticals AG - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Ganymed Pharmaceuticals AG - Product Pipeline Review - 2015’, provides an overview of the Ganymed Pharmaceuticals AG’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Givaudan: 2015 Strategic Direction, Marketing Tactics, Strengths and Weaknesses, Financial Performance
1/13/2015 | published by: VPGMarketResearch.com
Givaudan: 2015 Strategic Direction, Marketing Tactics, Strengths and Weaknesses, Financial Performance This unique report provides information not available from any other published source, including: Specific business, new product development and marketing objectives and strategies, including internal expansion,  |  read more...
USD 950
Registered Social Landlords (UK) - Industry Report
1/5/2015 | published by: Plimsoll Publishing Ltd.
Plimsoll’s UK Registered Social Landlords (UK) analysis is the most definitive and accurate study of the UK Registered Social Landlords (UK) sector in 2014. The report is split into two sections and uses both a written  |  read more...
USD 560
Genentech, Inc. - Product Pipeline Analysis, 2015 Update
2/6/2015 | published by: GlobalData
Summary Genentech, Inc. (Genentech) is one of the world's leading biotech companies. The company undertakes research, development, manufacture, and marketing of biotherapeutics. Genentech focuses on developing drugs for unmet medical needs in the areas of cancer,  |  read more...
USD 750
Market Operators (UK) - Industry Report
1/5/2015 | published by: Plimsoll Publishing Ltd.
Plimsoll’s UK Market Operators (UK) analysis is the most definitive and accurate study of the UK Market Operators (UK) sector in 2014. The report is split into two sections and uses both a written and graphical  |  read more...
USD 560
Galderma Partnering 2009-2014
11/1/2014 | published by: Current Partnering
Galderma Partnering 2009-2014 This report provides all the information you require to better understand Galderma and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies  |  read more...
USD 995
Genmab Partnering 2009-2014
11/1/2014 | published by: Current Partnering
Genmab Partnering 2009-2014 The Partnering Agreements with Genmab 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. This report provides all the information you require  |  read more...
USD 995
GlaxoSmithKline Partnering 2009-2014
11/1/2014 | published by: Current Partnering
GlaxoSmithKline Partnering 2009-2014 This report provides all the information you require to better understand GlaxoSmithKline and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those companies  |  read more...
USD 995
Gilead Sciences Inc (GILD: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/28/2014 | published by: Plunkett Research, Ltd.
Gilead Sciences Inc (GILD: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for (Gilead Sciences Inc, GILD: NAS) compared to its  |  read more...
USD 1,795
 

SELECT A LICENSE

    Online Download  USD 175  
    Global Site License  USD 438  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!